Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
ClinicalTrials.gov study NCT01903733. IPD Sharing: NO. Countries: 29. Publications: 1.
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03654768. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)
ClinicalTrials.gov study NCT01570868. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
ClinicalTrials.gov study NCT00451035. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT03289910. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transp
ClinicalTrials.gov study NCT01640301. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00103844. IPD Sharing: Not stated. Countries: 32. Publications: 2.
A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00481247. IPD Sharing: Not stated. Countries: 27. Publications: 6.
Underlying data for The Impact of ABCB1 (rs1045642 and rs117068084) Gene Polymorphisms on Response to Imatinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients
<p>Underlying data for The Impact of ABCB1 (rs1045642 and rs117068084) Gene Polymorphisms on Response to Imatinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients </p>
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
ClinicalTrials.gov study NCT01511289. IPD Sharing: Not stated. Countries: 4. Publications: 1.
"Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"
ClinicalTrials.gov study NCT05543161. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
ClinicalTrials.gov study NCT01784068. IPD Sharing: YES. Countries: 19. Publications: 0.
A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT04126681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phas
ClinicalTrials.gov study NCT01220648. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00478985. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Symptom Burden in Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01046305. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
ClinicalTrials.gov study NCT04150471. IPD Sharing: NO. Countries: 1. Publications: 1.
Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy
ClinicalTrials.gov study NCT00858806. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
ClinicalTrials.gov study NCT02852486. IPD Sharing: YES. Countries: 1. Publications: 15.
Patient Reported Outcomes in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01252589. IPD Sharing: Not stated. Countries: 10. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.